| Trade name of the product: |
| Rapaflo |
| Pharmaceutical active ingredients: |
| Silodosin |
| Available forms, composition and doses of Rapaflo: |
| Capsules; Oral; Silodosin 4 mgCapsules; Oral; Silodosin 8 mg |
| Medical categories: |
| Human:Alpha1-adrenoceptor antagonistsBenign prostatic hyperplasia (BPH) symptomatic treatment medications |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Watson PharmaceuticalsKissei Pharmaceutical |
| Related documents and information about Rapaflo: |
| Rapaflo prescribing information (PDF) |